Barclays’s enVVeno Medical NVNO Stock Holding History

Barclays’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2	Closed	-$21	–	5628
2026 Q2	$21	Buy	+2	New	+$22	﹤0.01%	5285
2020 Q1	–	Hold	0	–	–	–	6362
2019 Q4	–	Hold	0	–	–	–	6663

Other funds holding NVNO

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Barclays's NVNO Position: Q3 2026 in Review

Barclays sold out of enVVeno Medical (NVNO) in Q3 2026, closing a stake of 2 shares — an estimated $21 sold.

Barclays first reported a position in NVNO in Q2 2026 and held it in 1 quarter. The position peaked at $21 in Q2 2026. 3 funds tracked by Wall St. Rank hold NVNO as of Q3 2026.

Barclays reported no remaining enVVeno Medical position as of Q3 2026 after selling out during the quarter.
Barclays sold 2 enVVeno Medical shares in Q3 2026, an estimated $21.
Barclays first reported a position in enVVeno Medical in Q2 2026 and held it in 1 quarter.
Barclays's enVVeno Medical position peaked at $21 in Q2 2026.
3 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.